Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase I safety and imaging performance study of VB5-845D-800CW for intraoperative detection of gastrointestinal cancer
NL-OMON27469Phase 1Recruiting
- Sponsor
- Leiden University Medical Center
- Start
- Nov 2018
- Modality
- Antibody Fragments → Engineered Antibody Formats → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 1, open-label trial of VB5-845D-800CW in gastrointestinal cancer, colorectal cancer (CRC), esophageal cancer and 2 more, sponsored by Leiden University Medical Center. Started Nov 2018; status: recruiting.
02
Drugs
VB5-845D-800CW
03
Conditions
gastrointestinal cancercolorectal cancer (CRC)esophageal cancergastric cancer (GC)rectosigmoid cancer
Beyond the preview
Go deeper on NL-OMON27469.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON27469.